Drug-Device Combination s Market

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.

Drug-Device Combination s Market contains market size and forecasts of Drug-Device Combination Products in Global, including the following market information:

Global Drug-Device Combination Products Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Drug-Device Combination Products market was valued at 36220 million in 2021 and is projected to reach US$ 54360 million by 2028, at a CAGR of 6.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug-Coated Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drug-Device Combination Products include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Drug-Device Combination Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drug-Device Combination Products Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Drug-Device Combination Products Market Segment Percentages, by Type, 2021 (%)

Drug-Coated Device

Prefilled Drug Delivery Systems

Nebulizer and Inhaler

Transdermal Delivery System

Others

Global Drug-Device Combination Products Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Drug-Device Combination Products Market Segment Percentages, by Application, 2021 (%)

Hospital andClinic

Retail Pharmacies

Other

Global Drug-Device Combination Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Drug-Device Combination Products Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drug-Device Combination Products revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Drug-Device Combination Products revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK

Novo Nordisk

Eli Lilly

AstraZeneca

Sanofi

Boston Scientific

Abbott

Boehringer Ingelheim

Medtronic

Mylan

3M

Hisamitsu

Smith & Nephew

Molnlycke

Teleflex

BD

Lepu Medical

MicroPort

Terumo

B. Braun

Antares Pharma